Nicholas Regan

407 total citations
7 papers, 334 citations indexed

About

Nicholas Regan is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Nicholas Regan has authored 7 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Nicholas Regan's work include Sulfur Compounds in Biology (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Nicholas Regan is often cited by papers focused on Sulfur Compounds in Biology (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). Nicholas Regan collaborates with scholars based in United States. Nicholas Regan's co-authors include Pui‐Kai Li, Deepak K. Bhasin, Chenglong Li, Bulbul Pandit, Katryna Cisek, Jiayuh Lin, Dalia Abdelhamid, James R. Fuchs, Jiayuh Lin and Jonathan P. Etter and has published in prestigious journals such as Biochemical Journal, British Journal of Cancer and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Nicholas Regan

7 papers receiving 333 citations

Peers

Nicholas Regan

MB

ONCOL

MM

PFM

OC

Yuichi Kakudo Japan

Shao‐Hsing Weng Taiwan

Xiaomei Jiang China

Hong‐May Sim United States

Weiyan Cheng China

Andrew A. Godfrey United Kingdom

Andrew G. Jobson United States

Naif A. Al-Jomah Saudi Arabia

Ya-Fan Liao Taiwan

Yuichi Kakudo Japan

Nicholas Regan

286 ×1.5

MB

145 ×1.1

ONCOL

198 ×2.6

MM

26 ×0.4

PFM

68 ×1.2

OC

Citations per year, relative to Nicholas Regan Nicholas Regan (= 1×) peers Yuichi Kakudo

Countries citing papers authored by Nicholas Regan

Since Specialization

Citations

This map shows the geographic impact of Nicholas Regan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Regan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Regan more than expected).

Fields of papers citing papers by Nicholas Regan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Regan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Regan. The network helps show where Nicholas Regan may publish in the future.

Co-authorship network of co-authors of Nicholas Regan

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Regan. A scholar is included among the top collaborators of Nicholas Regan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Regan. Nicholas Regan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Arend, Rebecca C., Somsundaram Chettiar, Nicholas Regan, et al.. (2015). Niclosamide Analogs for Treatment of Ovarian Cancer. International Journal of Gynecological Cancer. 25(8). 1377–1385. 20 indexed citations

2.

Wickham, Stephanie, Nicholas Regan, Matthew West, et al.. (2013). Inhibition of human γ-glutamyl transpeptidase: development of more potent, physiologically relevant, uncompetitive inhibitors. Biochemical Journal. 450(3). 547–557. 29 indexed citations

3.

Wú, Xiànghóng, Lisheng Wang, Yaohua Han, et al.. (2011). Creating Diverse Target-Binding Surfaces on FKBP12: Synthesis and Evaluation of a Rapamycin Analogue Library. ACS Combinatorial Science. 13(5). 486–495. 26 indexed citations

4.

Wickham, Stephanie, Nicholas Regan, Matthew West, et al.. (2011). Divergent effects of compounds on the hydrolysis and transpeptidation reactions of γ-glutamyl transpeptidase. Journal of Enzyme Inhibition and Medicinal Chemistry. 27(4). 476–489. 10 indexed citations

5.

Fuh, Beng, Matthew Sobo, Brian Hutzen, et al.. (2009). LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model. British Journal of Cancer. 100(1). 106–112. 75 indexed citations

6.

Fuchs, James R., Bulbul Pandit, Deepak K. Bhasin, et al.. (2009). Structure–activity relationship studies of curcumin analogues. Bioorganic & Medicinal Chemistry Letters. 19(7). 2065–2069. 98 indexed citations

7.

Bhasin, Deepak K., Katryna Cisek, Trupti Pandharkar, et al.. (2007). Design, synthesis, and studies of small molecule STAT3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 391–395. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact